EKF Diagnostics (LON:EKF) Stock Price Down 7% – Time to Sell?

Shares of EKF Diagnostics Holdings plc (LON:EKF) traded down 7% during trading on Saturday . The company traded as low as GBX 23.60 ($0.31) and last traded at GBX 26 ($0.35). 2,281,890 shares were traded during trading, an increase of 404% from the average session volume of 453,091 shares. The stock had previously closed at GBX 27.95 ($0.37).

EKF Diagnostics Trading Down 7.0%

The firm has a market capitalization of £116.76 million, a price-to-earnings ratio of 19.26 and a beta of 0.57. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.77 and a current ratio of 4.60. The business has a fifty day moving average price of GBX 29.18 and a 200 day moving average price of GBX 26.59.

EKF Diagnostics (LON:EKF) last released its quarterly earnings data on Tuesday, September 16th. The company reported GBX 0.43 EPS for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. As a group, equities analysts forecast that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current year.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

? Point-of-Care analysers in the key areas of Hematology and Diabetes

? Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.